PMID: 15703542Feb 11, 2005Paper

Circadian disruption and breast cancer: from melatonin to clock genes

Epidemiology
Richard Stevens

Abstract

The global impact of breast cancer is large and growing. It seems clear that something about modern life is the culprit, yet there is thus far a lack of satisfactory explanations for most of the increases in risk as societies industrialize. Support has developed for a possible role of "circadian disruption," particularly from an altered-lighted environment (such as light at night). Lighting during the night of sufficient intensity can disrupt circadian rhythms, including reduction of circulating melatonin levels and resetting of the circadian pacemaker of the suprachiasmatic nuclei. Reduced melatonin may increase breast cancer risk through several mechanisms, including increased estrogen production and altered estrogen receptor function. The genes that drive the circadian rhythm are emerging as central players in gene regulation throughout the organism, particularly for cell-cycle regulatory genes and the genes of apoptosis. Aspects of modern life that can disrupt circadian rhythms during the key developmental periods (eg, in utero and during adolescence) may be particularly harmful. Epidemiologic studies should consider gene and environment interactions such as circadian gene variants and shift work requirements on the job.

References

Feb 1, 1992·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·R G StevensB W Wilson
Apr 21, 1990·Lancet·D Trichopoulos
Apr 1, 1987·American Journal of Epidemiology·R G Stevens
May 1, 1982·American Journal of Epidemiology·R G StevensJ A Lee
Dec 12, 1980·Science·A J LewyS P Markey
Sep 9, 1995·BMJ : British Medical Journal·Eero PukkalaG Wahlberg
Jan 5, 1995·The New England Journal of Medicine·Charles A CzeislerJ F Rizzo
Dec 1, 1995·Journal of Biological Rhythms·R J ColeS Juarez
Jun 1, 1996·Journal of Comparative Physiology. A, Sensory, Neural, and Behavioral Physiology·T Yoshimura, Shizufumi Ebihara
Mar 1, 1996·Cancer Causes & Control : CCC·T TynesT Haldorsen
Sep 1, 1996·Environmental Health Perspectives·I H Russo, J Russo
Jan 16, 1997·The New England Journal of Medicine·A Brzezinski
May 1, 1997·Breast Cancer Research and Treatment·C NagataH Shimizu
Sep 8, 1998·Epidemiology·M FeychtingA Ahlbom
Oct 21, 1998·Sleep·D KatzenbergE Mignot
Jun 26, 1999·Science·Charles A CzeislerR E Kronauer
Jul 29, 1999·British Journal of Cancer·P K VerkasaloS L Rudanko
Sep 2, 1999·Biochemical and Biophysical Research Communications·T EbisawaT Yamauchi
Jan 5, 2000·Cancer Causes & Control : CCC·N Potischman, R Troisi
Mar 1, 2000·Cancer Letters·L E AndersonRichard Stevens
Mar 18, 2000·Advances in Experimental Medicine and Biology·G J Maestroni
Feb 13, 2001·British Journal of Cancer·J KliukieneA Andersen
Aug 2, 2001·Journal of the National Cancer Institute·B A CohnP K Siiteri
Aug 17, 2001·Journal of Biological Rhythms·T A Wehr
Oct 17, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·D M ParkinS S Devesa
Oct 18, 2001·Journal of the National Cancer Institute·S DavisR G Stevens
Oct 18, 2001·Journal of the National Cancer Institute·Eva S SchernhammerGraham A Colditz
Feb 28, 2002·Breast Cancer Research and Treatment·T KieferS M Hill
May 2, 2002·Journal of the National Cancer Institute·Elisabeth FilipskiFrancis Lévi
May 23, 2002·Cell·Satchidananda PandaJohn B Hogenesch
Jun 21, 2002·Annals of the New York Academy of Sciences·Russel J Reiter, Du-Xian Tan
Oct 17, 2002·American Journal of Industrial Medicine·Barbara GriefahnGisela Degen
Jan 11, 2003·Science·Michael Menaker
Mar 26, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Carolina JohanssonTimo Partonen
May 2, 2003·Nature Reviews. Cancer·Loning Fu, Cheng Chi Lee
Jun 6, 2003·The New England Journal of Medicine·Ann S Hamilton, Thomas M Mack
Sep 2, 2003·Trends in Neurosciences·Russell N Van Gelder
Sep 13, 2003·The Journal of Clinical Endocrinology and Metabolism·Steven W LockleyCharles A Czeisler

Citations

Apr 25, 2007·Breast Cancer Research and Treatment·Yong ZhuTongzhang Zheng
Jun 2, 2007·Breast Cancer Research and Treatment·V SrinivasanG J Maestroni
Feb 5, 2010·Breast Cancer Research and Treatment·Eun-Young OhW J Hrushesky
Jul 4, 2012·Breast Cancer Research and Treatment·Cheryl L Thompson, Li Li
Apr 6, 2006·Cancer Causes & Control : CCC·John D BulloughMariana G Figueiro
Apr 6, 2006·Cancer Causes & Control : CCC·Richard Stevens
Apr 6, 2006·Cancer Causes & Control : CCC·Cheng Chi Lee
Apr 6, 2006·Cancer Causes & Control : CCC·Maximilian MoserRichard Stevens
Feb 11, 2012·Current Neurology and Neuroscience Reports·Ilia N Karatsoreos
Dec 1, 2006·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·José Angel García-SáenzEduardo Díaz-Rubio
Nov 15, 2011·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Cheng-Ming HsuMing-Yu Yang
Nov 26, 2009·Nature Reviews. Cancer·Saurabh Sahar, Paolo Sassone-Corsi
Jan 24, 2009·Proceedings of the National Academy of Sciences of the United States of America·Tae-Hong KangAziz Sancar
Feb 4, 2009·Proceedings of the National Academy of Sciences of the United States of America·Nuri OzturkAziz Sancar
Sep 19, 2006·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Alvaro Arjona, Dipak K Sarkar
Apr 22, 2009·International Journal of Epidemiology·Richard Stevens
Jan 7, 2010·Occupational Medicine·Josephine Arendt
Apr 2, 2008·Epidemiology·Jennifer L MarinoScott Davis
Apr 19, 2008·Cold Spring Harbor Symposia on Quantitative Biology·Sigal Gery, H Phillip Koeffler
Jan 26, 2006·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Yong ZhuPeter Boyle
Nov 21, 2009·Integrative Cancer Therapies·Jaclyn GuessW J Hrushesky
Apr 19, 2013·International Journal of Health Geographics·Sarah E BauerJohn E Vena
Aug 12, 2006·Journal of Carcinogenesis·Mariana G FigueiroJohn D Bullough
Apr 12, 2005·International Seminars in Surgical Oncology : ISSO·M SalhabK Mokbel
Mar 13, 2008·Journal of Circadian Rhythms·Shulin XiangSteven M Hill
Jul 5, 2013·Breast Cancer Research : BCR·Shanbeh ZienolddinyKristina Kjærheim
Sep 7, 2007·Environmental Health Perspectives·Richard StevensLeslie Reinlib
Jun 26, 2007·Environmental Health Perspectives·Clifford S MitchellMeryl H Karol
Jul 20, 2012·Molecular Medicine·Christos Savvidis, Michael Koutsilieris
Oct 13, 2011·Croatian Medical Journal·Pavel KavcicMario Poljak
Feb 28, 2013·International Journal of Molecular Sciences·Jun Du, Ren Xu
Feb 2, 2013·Journal of Circadian Rhythms·Natalia PaladinoDiego A Golombek
Mar 24, 2006·Proceedings of the National Academy of Sciences of the United States of America·Jennifer S PerrinShimon Amir
Apr 9, 2014·BMC Gastroenterology·Ming-Luen HuMing-Yu Yang
Jan 19, 2006·Journal of Women's Health·Alessandra BujaFrancesca Dominici
Oct 12, 2012·The Journal of School Nursing : the Official Publication of the National Association of School Nurses·Mayumi A Willgerodt, Gail M Kieckhefer
Dec 13, 2005·Journal of Occupational and Environmental Medicine·Marilyn J BorugianK Aronson
Mar 14, 2007·Journal of Occupational and Environmental Medicine·Jane A McElroyPolly A Newcomb
Jun 24, 2011·Journal of Occupational and Environmental Medicine·Mark McPhersonK Aronson
Sep 2, 2005·Epidemiology·Robert E Tarone
Jun 29, 2006·Epidemiology·Robert E Tarone
Aug 7, 2013·Electromagnetic Biology and Medicine·Abraham R Liboff

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis